SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-307884
Filing Date
2019-12-06
Accepted
2019-12-06 09:49:03
Documents
11
Period of Report
2019-12-06

Document Format Files

Seq Description Document Type Size
1 6-K d824147d6k.htm 6-K 35525
2 EX-2.1 d824147dex21.htm EX-2.1 91208
3 EX-2.2 d824147dex22.htm EX-2.2 81397
4 EX-4.1 d824147dex41.htm EX-4.1 126308
5 EX-4.2 d824147dex42.htm EX-4.2 297096
6 EX-4.3 d824147dex43.htm EX-4.3 34328
7 EX-4.4 d824147dex44.htm EX-4.4 46255
8 EX-99.1 d824147dex991.htm EX-99.1 77337
9 EX-99.2 d824147dex992.htm EX-99.2 19436
10 GRAPHIC g824147dsp21.jpg GRAPHIC 3081
11 GRAPHIC g824147g1206192455487.jpg GRAPHIC 4678
  Complete submission text file 0001193125-19-307884.txt   821009
Mailing Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB
Business Address 136A EASTERN AVENUE MILTON PARK ABINGDON X0 OX14 4SB 44-123-544-3939
Summit Therapeutics plc (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0131
Type: 6-K | Act: 34 | File No.: 001-36866 | Film No.: 191271921
SIC: 2834 Pharmaceutical Preparations